Compare BX & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BX | ELV |
|---|---|---|
| Founded | 1985 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0B | 85.7B |
| IPO Year | 2007 | 2001 |
| Metric | BX | ELV |
|---|---|---|
| Price | $125.44 | $390.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 19 |
| Target Price | $156.53 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 4.4M | 1.4M |
| Earning Date | 04-23-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.96% | 1.83% |
| EPS Growth | ★ 6.91 | N/A |
| EPS | 0.83 | ★ 8.00 |
| Revenue | $14,450,265,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $12.40 | N/A |
| Revenue Next Year | $23.10 | $3.07 |
| P/E Ratio | $150.90 | ★ $49.00 |
| Revenue Growth | 9.22 | ★ 12.49 |
| 52 Week Low | $101.73 | $273.71 |
| 52 Week High | $190.09 | $426.98 |
| Indicator | BX | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 57.82 | 49.39 |
| Support Level | $104.76 | $384.30 |
| Resistance Level | $128.24 | $408.00 |
| Average True Range (ATR) | 4.34 | 11.28 |
| MACD | 1.30 | -3.29 |
| Stochastic Oscillator | 79.42 | 12.20 |
Blackstone is the world's largest alternative-asset manager with $1.304 trillion in total assets under management, including $937.6 billion in fee-earning assets under management, at the end of March 2026. The company operates with scale in each of its major product lines: private equity (27% of fee-earning AUM and 34% of base management fees), real estate/real assets (30% and 33%), credit and insurance (33% and 26%), and other alternatives (10% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.